The Lawsuit brought on by former CEO (TC) and SH’s to return shares is pending.
There is also the Pestel suit pending that was filed prior.
IMO those are not the major issues.
Major concern is no BLA Acceptance. The timeline has been stretched to unacceptable proportions. Nader isn’t missing by months he’s missing by years. We should have been a revenue producing company in 2019. We will be fortunate if we produce revenue in 2021. The burn rate and pressure to dilute is coming soon. The S/C outcome - EUA or full approval would solve the financing.
For the ST I am bullish on LL and the likelihood of a Covid play for S/C. The absence of catalysts between now and then will create downward pressure on the SP.
Long term - many promising trials w a ways to go. Get the HIV Combo indication approved and build the pipeline.
The Nader dance is not something I want to be invested in LT and that’s what investors are going to be in for if S/C trial busts.
Market Data 
Markets 
AI
